ATTR-ACT Trial - Efficacy and Safety of Tafamidis in Transthyretin Amyloid Cardiomyopathy

27 August 2018 (11:02 - 11:12)
Organised by:
Congress Presentation Part of: Hot Line Session 3 Neurologic Disorders and Heart Disease ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by